News | Artificial Intelligence | May 16, 2018

Matrix Analytics Announces Company Rebrand to Eon

Rebranded company will bring optimized artificial intelligence and machine learning resources to conditions beyond lung cancer

Matrix Analytics Announces Company Rebrand to Eon

May 16, 2018 – Denver-based Matrix Analytics announced the company's rebrand to Eon. The rebrand marks the expansion of Eon's offerings beyond LungDirect to a suite of software solutions that will help improve the treatment of complex conditions of any kind. LungDirect, which will be rebranded to EonDirect, is the first and only cloud-based software application for lung cancer screening and incidental nodule management that integrates seamlessly with hospital electronic medical records (EMRs), according to Eon.

Eon provides solutions that use proprietary artificial intelligence and machine learning to optimize diagnoses and treatment efficiency for any condition that requires complex patient management. The company's flagship product, EonDirect, streamlines data to ensure healthcare providers receive the right data at the right time to provide the most effective care for their patients. The company's first expansions will include management of patients with pancreatic, thyroid, liver and renal diseases.

Matrix Analytics was founded in 2015 by interventional pulmonologist Akrum ("Aki") Alzubaidi to address the prevalence of delayed or missed lung cancer diagnoses due to antiquated, inefficient hospital software systems. Leveraging his programming background, Alzubaidi developed LungDirect to better detect and diagnose pulmonary nodules, or spots on the lungs. The technology improved early-stage lung cancer detection at the hospital where Alzubaidi practiced from 23 percent to nearly 50 percent.

Since its founding, the company has largely grown through personal investment by its leaders, but Eon has also raised nearly $2 million in investments, with commitments for an additional $2 million by the end of May 2018. Eon's current advisors include:

  • Mark Cuban, entrepreneur, Dallas Mavericks owner and "Shark Tank" host;
  • George Conrades, IBM executive veteran, CEO of Akamai, board member for Harley Davidson and Oracle;
  • Kevin Hutchinson, entrepreneur, developer of Surescripts, MedicaLogic and Medscape, and CEO of MyTaskit;
  • Joseph Cicenia, M.D., pulmonologist at Cleveland Clinic; and
  • Zach and Chancy Love, private investors.

"EonDirect has added tremendous value to our hospital and is a great investment. In addition to being affordable, their technology has significantly reduced the amount of time our staff spends on administrative tasks and improved how we screen and treat our lung cancer patients," said Scott Skibo, M.D., pulmonologist at Haywood Regional Medical Center. "It is refreshing to work with a company that delivers on its promise and provides truly great customer service."

EonDirect is also being used in the Patient-Centered Outcomes Research Institute's (PCORI) "The Watch the Spot Trial" and is a Certified Software Partner of the American College of Radiology's Lung Cancer Screening Registry.

For more information: www.eonhealth.com

 

Related Content

Videos | Enterprise Imaging | December 14, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors highlighting EI
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing AI prod
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Lunit Announces New Prominent Radiology Advisory Board Members
News | Artificial Intelligence | December 11, 2018
Medical artificial intelligence (AI) software company Lunit announced three new members of its advisory board,...
Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
Fovia Launches F.A.S.T. AI Suite for PACS
Technology | Advanced Visualization | December 05, 2018
Fovia Inc. recently announced the release of a new artificial intelligence (AI) visualization platform, F.A.S.T. AI...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...